Entry |
|
Name |
Phenoxybenzamine hydrochloride
|
Formula |
C18H22ClNO. HCl
|
Exact mass |
339.1157
|
Mol weight |
340.2873
|
Structure |

|
Remark |
|
Brite |
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
C CARDIOVASCULAR SYSTEM
C04 PERIPHERAL VASODILATORS
C04A PERIPHERAL VASODILATORS
C04AX Other peripheral vasodilators
C04AX02 Phenoxybenzamine
D00507 Phenoxybenzamine hydrochloride (USP) <US>
USP drug classification [BR:br08302]
Cardiovascular Agents
Alpha-adrenergic Blocking Agents
Phenoxybenzamine
D00507 Phenoxybenzamine hydrochloride (USP)
Drug groups [BR:br08330]
Cardiovascular agent
DG01466 Adrenergic receptor antagonist
DG01465 alpha-Adrenergic receptor antagonist
DG00285 Phenoxybenzamine
D00507 Phenoxybenzamine hydrochloride
Target-based classification of drugs [BR:br08310]
G Protein-coupled receptors
Rhodopsin family
Adrenaline
ADRA1
D00507 Phenoxybenzamine hydrochloride (USP) <US>
ADRA2
D00507 Phenoxybenzamine hydrochloride (USP) <US>
|
Other DBs |
|
KCF data |
ATOM 22
1 C8y C 19.0534 -19.7291
2 C1b C 20.2630 -20.4268
3 C8x C 17.8498 -20.4268
4 C8x C 19.0534 -18.3511
5 N1c N 21.4608 -19.7291
6 C8x C 16.6520 -19.7291
7 C8x C 17.8498 -17.6474
8 C1c C 22.6528 -20.4268
9 C1b C 21.4608 -18.3511
10 C8x C 16.6520 -18.3511
11 C1b C 23.8564 -19.7291
12 C1a C 22.6528 -21.8165
13 C1b C 22.7516 -17.8799
14 O2a O 25.0658 -20.4268
15 X Cl 22.7516 -16.4903
16 C8y C 26.4789 -19.6536
17 C8x C 26.4438 -18.2696
18 C8x C 27.6650 -20.3745
19 C8x C 27.7348 -17.6068
20 C8x C 28.8977 -19.7058
21 C8x C 28.9209 -18.3335
22 X Cl 32.4796 -19.1999
BOND 22
1 1 2 1
2 1 3 1
3 1 4 2
4 2 5 1
5 3 6 2
6 4 7 1
7 5 8 1
8 5 9 1
9 6 10 1
10 8 11 1
11 8 12 1
12 9 13 1
13 11 14 1
14 13 15 1
15 14 16 1
16 16 17 1
17 16 18 2
18 17 19 2
19 18 20 1
20 19 21 1
21 7 10 2
22 20 21 2
|